etoposide has been researched along with Libman-Sacks Disease in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Junga, Z; Keith, M; Stitt, R; Tracy, C | 1 |
| Ailawadhi, S; Dholaria, B; Patel, RJ; Roy, V; Sluzevich, JC | 1 |
| Almuwaqqat, Z; Bashtawi, Y; Roberts, JW | 1 |
| Athanasopoulos, A; Daladimos, T; Kosmas, C; Papachrysanthou, T; Tsavaris, N; Vlachoyiannopoulos, PG | 1 |
| Capria, S; Mandelli, F; Meloni, G; Modena, V; Vignetti, M | 1 |
5 other study(ies) available for etoposide and Libman-Sacks Disease
| Article | Year |
|---|---|
Novel use of rituximab in macrophage activation syndrome secondary to systemic lupus erythematosus.
Topics: Antineoplastic Agents, Immunological; Antirheumatic Agents; Diagnosis, Differential; Etoposide; Female; Humans; Hydroxychloroquine; Infusions, Intravenous; Lupus Erythematosus, Systemic; Macrophage Activation Syndrome; Rare Diseases; Rituximab; Treatment Outcome; Young Adult | 2017 |
Relapsed subcutaneous panniculitis-like T cell lymphoma: role of haploidentical hematopoietic stem cell transplant.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Histocompatibility; Humans; Ifosfamide; Lupus Erythematosus, Systemic; Lymphoma, T-Cell; Nephrosis, Lipoid; Nephrotic Syndrome; Panniculitis; Paraneoplastic Syndromes; Prednisolone; Recurrence; Remission Induction; Salvage Therapy; Vincristine | 2017 |
A rare and serious cause of pancytopenia in a patient with systemic lupus erythematosus: haemophagocytic lymphohistiocytosis.
Topics: Anti-Inflammatory Agents; Antineoplastic Agents, Phytogenic; Cyclosporine; Dexamethasone; Etoposide; Female; Ferritins; Humans; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Lymphohistiocytosis, Hemophagocytic; Middle Aged; Pancytopenia; Patient Comfort; Treatment Outcome | 2018 |
Control of relapsed germ cell tumor and SLE nephritis by high-dose chemotherapy and autologous hematopoietic cell transplantation.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Cyclophosphamide; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Lupus Erythematosus, Systemic; Lupus Nephritis; Male; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Prognosis; Salvage Therapy; Transplantation, Autologous; Young Adult | 2013 |
Blast crisis of chronic myelogenous leukemia in long-lasting systemic lupus erythematosus: regression of both diseases after autologous bone marrow transplantation.
Topics: Adult; Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Autoimmune Diseases; Blast Crisis; Bone Marrow Transplantation; Carmustine; Combined Modality Therapy; Cytarabine; Etoposide; Female; Humans; Idarubicin; Immunologic Factors; Interferon-alpha; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lupus Erythematosus, Systemic; Methotrexate; Prednisone; Remission Induction; Transplantation, Autologous; Vincristine | 1997 |